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ABSTRACT 
Objective:  Trigeminal neuralgia is the lancinating electric shock like pain because of neurovascular compression 
in trigeminal nerve distribution. We compared the efficacy of radiofrequency rhizotomy with microvascular 
decompression in terms of complete pain relief. 
Material and Methods:  The randomized controlled trial study was conducted in the neurosurgery department, 
LGH Lahore for a period of one year June 2017 to June 2018. A total of 110 patients were included and 
distributed into two groups, i.e. group-I who underwent radiofrequency rhizotomy (RFR) and group-II who 
underwent microvascular decompression (MVD). Follow-up of all the patients was assured up to six months. All 
the data were analyzed using S.P.S.S Ver. 23.0. 
Results:  There were 38 (34.6%) male and 72(65.4%) female. Mean age was 51.25 ± 8.80 years. At the end of six 
months, in Group-I (RFR), Nineteen (34.5%) patients were completely pain free, 25 (45.5%) patients had 
significant pain relief, 7 (12.7%) had mild improvement in the pain and 4 (7.3%) patients had no improvement in 
the pain. In group-II (MVD), 30 (54.5%) patients were completely pain free, 14 (25.5%) had significant pain 
relief, 9 (16.4%) had mild improvement and 2 (3.6%) had no improvement in their pain (Chi-square = 6.49, p = 
0.090). 
Conclusion:  Microvascular decompression had better results than a radiofrequency rhizotomy in patients 
presenting with trigeminal neuralgia regarding excellent pain relief and fewer complications. 
Keywords:  Microvascular decompression (MVD), Radiofrequency Rhizotomy (RFR), Trigeminal Neuralgia 
TGN). 
 
INTRODUCTION 
Trigeminal neuralgia (TGN) is frequently occurring 
unbearable, debilitating painful condition in patients 
with advancing age, i.e. 50 to 60 years old and is 
caused by neurovascular compression in trigeminal 
nerve distribution.
1,2
 It is usually triggered by non-
noxious stimuli and is characterized by involuntary 
and lancinating attacks of electric shock like pain.
3, 4
 
According to the studies, ~4.5 per 100,000 individuals 
suffer from trigeminal neuralgia with a female to male 
ratio of 2.5:1 and a positive family history in 5% of the 
cases.
2,5,6
 
 According to the current recommendations, 
anticonvulsant medications such as carbamazepine or 
oxcarbazepine are usually used as first-line therapy for 
the initial relief of pain.
4,7
 Most of the patients remain 
asymptomatic for a period of six months, but in four 
out five individuals, the pain with re-appear after the 
six months and up to fifty percent of the individuals 
will become resistant to the pharmacological treatment 
or experience adverse effects of the medications hence 
requiring the surgical intervention.
2,8
 
 According to a study by Zakrzewska et al. 
regarding the effectiveness of the surgical intervention, 
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78% of the patients told that during the initial course 
of their disease, they would have preferred this 
treatment.
9
 Among the primary surgical interventions, 
there are microvascular decompression, percutaneous 
rhizotomy and stereotactic radiosurgery.
10
 
Microvascular decompression (MVD) is an open 
method used when the surgeon needs to relieve the 
neurovascular compression and conserve the function 
of the trigeminal nerve.
11
 According to the studies, 
about 90% of the patients get pain free initially and 
above eighty percent remain pain relief after one year. 
Even after five years of surgery, 73% of the 
individuals don’t experience the pain and remain pain 
free.
2,12,13
 Percutaneous rhizotomy is however non-
invasive technique performed by approaching 
Gasserian ganglion by puncturing in the cheek with 
the help of a tew needle.
14
 According to the studies, 
about 90% of the patients get pain free initially and 
around 75% get pain relief after one year. However, 
after five years, about fifty percent of the patients 
present again with the history of recurrence of pain.
2,15
 
 This study was compared in order to compare the 
efficacy of radiofrequency rhizotomy (RFR) with 
microvascular decompression (MVD) in trigeminal 
neuralgia patients. The results of this study will be 
compared with national and international studies 
which will help the neurosurgeons approach and 
decide different surgical techniques in a diverse 
variety of patients. 
 
MATERIAL AND METHODS 
Study Design and Sampling 
After taking the approval from the ethical committee, 
this randomized controlled trial (RCT) study was 
conducted in the neurosurgery department Lahore 
General Hospital Lahore for a period of one year June 
2017 to June 2018. After taking the informed consent, 
detailed history and examination were performed. A 
total of 110 patients of either gender and between the 
ages of 35 to 65 years presenting with trigeminal 
neuralgia were included in this study. 
Inclusion Criteria 
The patients who had TGN refractory to the 
medication were also included in this study. 
 
Exclusion Criteria 
Patients who were pain-free after the pharmacological 
therapy or who presented with TGN due to secondary 
causes such as multiple sclerosis and tumors or those 
presenting with atypical TGN were excluded. 
 
Data Collection 
Demographic data were collected on a predefined 
questionnaire. A random distribution of all the patients 
were done using the lottery method in two equal 
groups, i.e. group-I patients underwent radiofrequency 
rhizotomy and group-II patients underwent 
microvascular decompression. After the procedure, the 
patients were kept under observation in the hospital 
and discharged once they were stable. Complications 
associated with the procedure were noted. Follow-up 
of the patients was done for six months. The efficacy 
was assessed in terms of complete pain relief. 
 
Data Analysis 
All the data were collected and explored using S.P.S.S 
Ver. 23.0. Mean and standard deviation were 
calculated for quantitative variables. Numbers and 
percentages were calculated for qualitative variables. 
In order to check the normality of the data Shapiro-
Wilk test was used. Suitable statistical techniques were 
used. The Chi-square test was done in order to analyze 
the associations between qualitative variables. P-value 
of ≤ 0.05 was taken as significant. 
 
RESULTS 
Gender Incidence 
There were 38 (34.6%) male and 72 (65.4%) female 
patients (Table 1). 
 
Table 1:  Descriptive statistics according to the groups. 
 
Group Age (Years) 
Disease 
Duration 
(Years) 
Gender 
Male Female 
RFR (n = 55) 51.27 ± 7.76 2.63 ± 1.86 18 (16.4%) 37 (33.6%) 
MVD (n = 55) 51.20 ± 9.81 3.722 ± 1.67 20 (18.2%) 35 (31.8%) 
Total 51.25 ± 8.80 3.18 ± 1.85 38 (34.6%) 72 (65.4%) 
 
 
Age Incidence 
Mean age of the patients was 51.25 
± 8.80 years with an age range of 
36-65 years. Twenty-three (20.91%) 
patients were between 35-45 years 
of age, 43 (39.09%) were between 
46-55 years and 44 (40.00%) 
patients were between 56-65 years 
of age. 
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Table 2:  Pain Improvement according different age groups. 
 
Groups 
Pain 
Improvement 
Age Groups (Years) 
Total 
%age (Per 
Group) 
Overall 
%age 
36 – 45 46 – 55 56 – 65 
RFR (n = 55) 
Complete 3 9 7 19 34.55 17.27 
Significant 4 12 9 25 45.45 22.73 
Mild 2 3 2 7 12.73 6.36 
No 1 1 2 4 7.27 3.64 
MVD (n = 55) 
Complete 7 12 11 30 54.55 27.27 
Significant 4 3 7 14 25.45 12.73 
Mild 1 3 5 9 16.36 8.18 
No 1 0 1 2 3.64 1.82 
Total 23 43 44 110 -- 100 
 
 
 
Graph 1:  Efficacy of Rhizotomy and MVD in terms of pain relief. 
 
Duration of Pain 
The mean duration of disease was 3.18 ± 1.85 years, 
with a minimum duration of 6 months and a maximum 
duration of 6.50 years (Table 1). 
Pain Relief 
Regarding the improvement in pain, in Group-I (RFR), 
Nineteen (34.5%) patients were completely pain free 
at the end of six months, 25 (45.5%) patients had 
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significant pain relief i.e. they felt pain only once or 
twice, 7 (12.7%) had mild improvement in the pain i.e. 
they felt the pain very often and 4 (7.3%) patients had 
no improvement in the pain. In group-II (MVD), 30 
(54.5%) patients were completely pain free, 14 
(25.5%) had significant pain relief, 9 (16.4%) had mild 
improvement and 2 (3.6%) had no improvement in 
their pain (Chi-square = 6.49, p = 0.090) (Table 2, 
Graph 1). 
 
Distribution of Pain 
In group-I patients, the pain was distributed as 27 
(49.09%) cases in V2 and V3, 15 (27.27%) cases in 
V1 and V2, 8 (14.54%) cases in V2 alone and 5 
(9.09%) cases in V1 alone. In group-II it was 
distributed as 26 (47.279%) cases in V2 and V3, 13 
(23.63%) cases in V1 and V2, 9 (16.36%) cases in V2 
alone and 7 (12.72%) cases in V1 alone. 
 
Complications 
In group-I (RFR) patients, 5 (9.09%) patients 
developed a hematoma, 4 (7.27%) patients developed 
Anesthesia dolorosa and 1 patient (1.81%) developed 
painful dysesthesia. No other complications were seen. 
In group-II (MVD) patients, 3 (5.45%) patients 
experienced CSF leak, 3 (5.45%) patients had wound 
infection and 1 patient (1.81%) developed aseptic 
meningitis. 
 
DISCUSSION 
The prime cause of the trigeminal neuralgia is 
demyelination of nerve afferents occurring due to 
neurovascular compression. The secondary trigeminal 
neuralgia may occur due to the multiple sclerosis or 
space-occupying pathologies. In our study, the mean 
age of the patients was 51.25 ± 8.80 years. This is in 
accordance with the study by Nanjappa et al., which 
states that the average age of onset of the trigeminal 
neuralgia is 53 years.
16
 Wang et al. reported the mean 
age of 63 years in patients who presented with 
trigeminal neuralgia and underwent microvascular 
decompression.
11
 The majority of the patients in our 
study were in 46 – 55 years (n = 43, 39.09%) and 56 – 
65 years (n = 44, 40.00%) group. In a study by Hung 
et al. 56.7% of patients were between 51 – 70 years of 
age.
17
 These findings are similar to our findings. 
Nanjappa et al. stated that in their study, the majority 
was in between 51 – 60 years.16 In our study, there was 
34.6% male and 65.4% female patients and female to 
male ratio was 1.9:1. These findings are similar to a 
study by Hang et al., who reported 41.4% male and 
58.6% female and a female to male of 1.42:1.
17
 Khan 
et al. reported female to male ratio of 1.30:1.
18
 
 In our study, patients who underwent 
radiofrequency rhizotomy, eighty percent of the 
patients showed complete pain relief to significant 
pain relief, i.e. 45.5% had significant pain relief and 
34.5% had complete pain relief. Nanjappa et al. 
performed rhizotomy on fifteen patients and reported 
that 80% of the patients showed excellent pain relief 
after a follow-up of six months.
16
 According to Xie 
et al. 87% of the patients reported pain relief after 
undergoing rhizotomy.
19
 In our study, 12.7% of the 
patients showed mild improvement and 7.3% showed 
no improvement.In a study by Kanpolat et al., the 
97.6% of the patients had complete pain relief 
immediately after the procedure, but at the end of six 
months, 7.7% of the patients started feeling again and 
again.
20
 Tronnier et al., also documented in their study 
that the fifty percent of the patients who underwent 
rhizotomy started feeling pain again after their first 
follow-up.
21
 
 The patients who underwent microvascular 
decompressions and 54.5% were completely pain-free 
and 25.5% had significant pain relief. Khan et al., 
noticed in their study that 68% of the patients who 
undertook microvascular decompression were 
completely pain-free and 26.45% had significant pain 
relief.
18
 Tronnier et al, documented that 76.4% of the 
patients remained pain-free after two years of 
microvascular decompression.
21
 Pagni et al. also 
acknowledged that patients undergoing microvascular 
decompression showed much better results than 
anyother technique.
22
 In our study, 3.6% patients who 
undertook microvascular decompression experienced 
no improvement in their pain. This is in accordance 
with the findings by Khan et al. who documented that 
5.6% of the patients had no improvement after MVD.
18
 
 
CONCLUSIONS 
Microvascular decompression had better results than a 
radiofrequency rhizotomy in patients presenting with 
trigeminal neuralgia regarding excellent pain relief and 
fewer complications. 
 
LIMITATIONS 
We didn’t follow the patients after the six months of 
the procedure. An extensive follow-up with larger 
number of patients should be carried out. 
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